{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:14:42Z","timestamp":1787505282616,"version":"build-2736575974"},"reference-count":44,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T00:00:00Z","timestamp":1680480000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020594","name":"GenSight Biologics SA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020594","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.ymthe.2023.03.035","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T21:25:52Z","timestamp":1680557152000},"page":"2005-2013","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Ocular stress enhances contralateral transfer of lenadogene nolparvovec gene therapy through astrocyte networks"],"prefix":"10.1016","volume":"31","author":[{"given":"Nolan R.","family":"McGrady","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Boal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Risner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magali","family":"Taiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose A.","family":"Sahel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8475-9959","authenticated-orcid":false,"given":"David J.","family":"Calkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2023.03.035_bib1","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.mito.2017.07.006","article-title":"The pattern of retinal ganglion cell dysfunction in Leber hereditary optic neuropathy","volume":"36","author":"Majander","year":"2017","journal-title":"Mitochondrion"},{"key":"10.1016\/j.ymthe.2023.03.035_bib2","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0161-6420(96)30665-9","article-title":"Ophthalmologic findings in Leber hereditary optic neuropathy, with special reference to mtDNA mutations","volume":"103","author":"Nikoskelainen","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2023.03.035_bib3","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1126\/science.3201231","article-title":"Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy","volume":"242","author":"Wallace","year":"1988","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.ymthe.2023.03.035_bib4","first-page":"939","article-title":"Leber hereditary optic neuropathy: identification of the same mitochondrial ND1 mutation in six pedigrees","volume":"49","author":"Howell","year":"1991","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymthe.2023.03.035_bib5","first-page":"481","article-title":"Primary pathogenic mtDNA mutations in multigeneration pedigrees with Leber hereditary optic neuropathy","volume":"59","author":"Mackey","year":"1996","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymthe.2023.03.035_bib6","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/WNO.0000000000001045","article-title":"Visual outcomes in leber hereditary optic neuropathy patients with the m.11778G>A (MTND4) mitochondrial DNA mutation","volume":"40","author":"Newman","year":"2020","journal-title":"J.\u00a0Neuroophthalmol."},{"key":"10.1016\/j.ymthe.2023.03.035_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063446","article-title":"Raised intraocular pressure as a potential risk factor for visual loss in Leber Hereditary Optic Neuropathy","volume":"8","author":"Thouin","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2023.03.035_bib8","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s40259-021-00468-9","article-title":"Safety of intravitreal gene therapy for treatment of subjects with leber hereditary optic neuropathy due to mutations in the mitochondrial ND4 gene: the REVEAL study","volume":"35","author":"Vignal-Clermont","year":"2021","journal-title":"BioDrugs."},{"key":"10.1016\/j.ymthe.2023.03.035_bib9","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.ophtha.2020.12.012","article-title":"Efficacy and safety of intravitreal gene therapy for leber hereditary optic neuropathy treated within 6 Months of disease onset","volume":"128","author":"Newman","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2023.03.035_bib10","doi-asserted-by":"crossref","first-page":"E1238","DOI":"10.1073\/pnas.1119577109","article-title":"Gene delivery to mitochondria by targeting modified adenoassociated virus suppresses Leber's hereditary optic neuropathy in a mouse model","volume":"109","author":"Yu","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2023.03.035_bib11","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.bbamcr.2008.04.018","article-title":"The optimized allotopic expression of ND1 or ND4 genes restores respiratory chain complex I activity in fibroblasts harboring mutations in these genes","volume":"1783","author":"Bonnet","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymthe.2023.03.035_bib12","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1089\/rej.2006.0526","article-title":"Allotopic mRNA localization to the mitochondrial surface rescues respiratory chain defects in fibroblasts harboring mitochondrial DNA mutations affecting complex I or v subunits","volume":"10","author":"Bonnet","year":"2007","journal-title":"Rejuvenation Res."},{"key":"10.1016\/j.ymthe.2023.03.035_bib13","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz7423","article-title":"Bilateral visual improvement with unilateral gene therapy injection for Leber hereditary optic neuropathy","volume":"12","author":"Yu-Wai-Man","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2023.03.035_bib14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/WNO.0000000000001367","article-title":"Long-term follow-up after unilateral intravitreal gene therapy for leber hereditary optic neuropathy: the RESTORE study","volume":"41","author":"Biousse","year":"2021","journal-title":"J.\u00a0Neuroophthalmol."},{"key":"10.1016\/j.ymthe.2023.03.035_bib15","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.omtm.2021.09.013","article-title":"Biodistribution of intravitreal (lenadogene) nolparvovec gene therapy in nonhuman primates","volume":"23","author":"Calkins","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2023.03.035_bib16","doi-asserted-by":"crossref","first-page":"18810","DOI":"10.1073\/pnas.2009425117","article-title":"Redistribution of metabolic resources through astrocyte networks mitigates neurodegenerative stress","volume":"117","author":"Cooper","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2023.03.035_bib17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/978-1-4939-7407-8_3","article-title":"The microbead occlusion model of ocular hypertension in mice","volume":"1695","author":"Calkins","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ymthe.2023.03.035_bib18","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/em.20586","article-title":"Mitochondrial DNA mutations in disease and aging","volume":"51","author":"Wallace","year":"2010","journal-title":"Environ. Mol. Mutagen."},{"key":"10.1016\/j.ymthe.2023.03.035_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2020.101039","article-title":"Astrocyte mitochondria: central players and potential therapeutic targets for neurodegenerative diseases and injury","volume":"59","author":"Gollihue","year":"2020","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ymthe.2023.03.035_bib20","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.mito.2017.08.014","article-title":"Mitochondrial dynamics, transport, and quality control: a bottleneck for retinal ganglion cell viability in optic neuropathies","volume":"36","author":"Ito","year":"2017","journal-title":"Mitochondrion"},{"key":"10.1016\/j.ymthe.2023.03.035_bib21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.preteyeres.2003.10.003","article-title":"Mitochondrial dysfunction as a cause of optic neuropathies","volume":"23","author":"Carelli","year":"2004","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ymthe.2023.03.035_bib22","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1167\/iovs.09-5115","article-title":"Optic neuropathy due to microbead-induced elevated intraocular pressure in the mouse","volume":"52","author":"Chen","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2023.03.035_bib23","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13024-021-00459-y","article-title":"Neuroprotection by Wld(S) depends on retinal ganglion cell type and age in glaucoma","volume":"16","author":"Risner","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ymthe.2023.03.035_bib24","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1007\/s12035-021-02675-5","article-title":"Bax contributes to retinal ganglion cell dendritic degeneration during glaucoma","volume":"59","author":"Risner","year":"2022","journal-title":"Mol. Neurobiol."},{"issue":"Suppl 1","key":"10.1016\/j.ymthe.2023.03.035_bib25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/1440-1681.12764","article-title":"The mobility of mitochondria: intercellular trafficking in health and disease","volume":"44","author":"Berridge","year":"2017","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ymthe.2023.03.035_bib26","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1126\/science.1258295","article-title":"Neuroscience. Astrocytes eyeball axonal mitochondria","volume":"345","author":"Burdett","year":"2014","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.ymthe.2023.03.035_bib27","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00418-012-1045-x","article-title":"Astrocytes shed large membrane vesicles that contain mitochondria, lipid droplets and ATP","volume":"139","author":"Falchi","year":"2013","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.ymthe.2023.03.035_bib28","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3389\/fcell.2016.00107","article-title":"Mitochondria know No boundaries: mechanisms and functions of intercellular mitochondrial transfer","volume":"4","author":"Torralba","year":"2016","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ymthe.2023.03.035_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/cells8030275","article-title":"Mitochondrial retrograde signalling and metabolic alterations in the tumour microenvironment","volume":"8","author":"Yang","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.ymthe.2023.03.035_bib30","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3389\/fncel.2019.00373","article-title":"Axonal transport and mitochondrial function in neurons","volume":"13","author":"Mandal","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ymthe.2023.03.035_bib31","doi-asserted-by":"crossref","first-page":"9633","DOI":"10.1073\/pnas.1404651111","article-title":"Transcellular degradation of axonal mitochondria","volume":"111","author":"Davis","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2023.03.035_bib32","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ymthe.2004.09.022","article-title":"Biodistribution of rAAV vectors following intraocular administration: evidence for the presence and persistence of vector DNA in the optic nerve and in the brain","volume":"11","author":"Provost","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2023.03.035_bib33","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","article-title":"Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial","volume":"390","author":"Russell","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2023.03.035_bib34","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ophtha.2015.10.025","article-title":"Gene therapy for leber hereditary optic neuropathy: initial results","volume":"123","author":"Feuer","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2023.03.035_bib35","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.ophtha.2017.05.016","article-title":"Gene therapy for leber hereditary optic neuropathy: low- and medium-dose visual results","volume":"124","author":"Guy","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2023.03.035_bib36","article-title":"Efficacy and safety of rAAV2-ND4 treatment for leber's hereditary optic neuropathy","volume":"6","author":"Wan","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2023.03.035_bib37","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000487485","article-title":"Visual field variability after gene therapy for leber's hereditary optic neuropathy","volume":"60","author":"Yuan","year":"2018","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.ymthe.2023.03.035_bib38","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.ophtha.2020.02.023","article-title":"Seven-year follow-up of gene therapy for leber's hereditary optic neuropathy","volume":"127","author":"Yuan","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2023.03.035_bib39","doi-asserted-by":"crossref","first-page":"e730","DOI":"10.1111\/aos.14379","article-title":"Factors associated with rapid improvement in visual acuity in patients with Leber's hereditary optic neuropathy after gene therapy","volume":"98","author":"Liu","year":"2020","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.ymthe.2023.03.035_bib40","doi-asserted-by":"crossref","first-page":"591","DOI":"10.47102\/annals-acadmedsg.V37N7p591","article-title":"Effects on the contralateral eye after intravitreal bevacizumab and ranibizumab injections: a case report","volume":"37","author":"Wu","year":"2008","journal-title":"Ann. Acad. Med. Singap."},{"key":"10.1016\/j.ymthe.2023.03.035_bib41","first-page":"400","article-title":"Bilateral response following unilateral intravitreal bevacizumab injection in a child with uveitic cystoid macular edema","volume":"13","author":"Al-Dhibi","year":"2009","journal-title":"J.\u00a0Aapos"},{"key":"10.1016\/j.ymthe.2023.03.035_bib42","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/eye.2014.94","article-title":"Fellow eye effect of unilateral intravitreal bevacizumab injection in eyes with diabetic macular edema","volume":"28","author":"Hanhart","year":"2014","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ymthe.2023.03.035_bib43","article-title":"Therapeutic effect of anti-VEGF for age-related macular degeneration in the untreated fellow eye","volume":"2018","author":"Isildak","year":"2018","journal-title":"Case Rep. Ophthalmol. Med."},{"key":"10.1016\/j.ymthe.2023.03.035_bib44","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1167\/iovs.03-0039","article-title":"Optic nerve degeneration in a murine model of juvenile ceroid lipofuscinosis","volume":"44","author":"Sappington","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001623001958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001623001958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:09:54Z","timestamp":1761502194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001623001958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":44,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S1525001623001958"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2023.03.035","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ocular stress enhances contralateral transfer of lenadogene nolparvovec gene therapy through astrocyte networks","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2023.03.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors.","name":"copyright","label":"Copyright"}]}}